CoinDesk 20 Performance Update: Bitcoin Cash (BCH) Gains 4.2%, Leading Index Higher
Near Protocol (NEAR) joined Bitcoin Cash (BCH) as a top performer, rising 3.7% from Wednesday.
1 Small-Cap Stock to Own for Decades and 2 to Steer Clear Of
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
1 S&P 500 Stock for Long-Term Investors and 2 to Turn Down
While the S&P 500 includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
3 of Wall Street’s Favorite Stocks Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
3 of Wall Street’s Favorite Stocks Showing Warning Signs
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results
Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released clinical trial results for its oral weight-loss drug that "demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines."
Huntington's Q1 profit rises as Fed rate cuts temper deposit costs
U.S. President Donald Trump's trade policies have sparked concerns about rising inflation and a potential recession, prompting the bank to set aside a bigger buffer to cover loans that might not be repaid. Huntington's provision for credit losses was $115 million, higher than $107 million from a year earlier. Its net interest income - the difference between what a bank earns as interest on loans and pays out on deposits - jumped to $1.43 billion in the first quarter, compared with $1.29 billion a year earlier.
US jobless benefit claims fall last week as labor market remains strong despite recession fears
U.S. applications for jobless benefits fell again last week as the labor market continues to hold up despite fears of a tariff-induced recession. Jobless claim applications fell by 9,000 to 215,000 for the week ending April 12, the Labor Department said Thursday. Weekly applications for jobless benefits are considered a proxy for layoffs, and have mostly stayed between 200,000 and 250,000 for the past few years.